ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,150Medicare Part D Prescriptions Filled, Including Refills

Rank: 266 out of 676

$413K Total Retail Price of All Prescriptions

Rank: 270 out of 676

395 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 6,136 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 407 280 1 3
FUROSEMIDE 297 231 2 4
CARVEDILOL 286 229 3 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 240 191 4 16
HYDROCHLOROTHIAZIDE 224 161 5 12
LOSARTAN-HYDROCHLOROTHIAZIDE 218 117 6 51
SIMVASTATIN 212 174 7 6
ATORVASTATIN CALCIUM 185 130 8 20
WARFARIN SODIUM 181 152 9 18
KLOR-CON M20 180 133 10 67
METFORMIN HCL 170 129 11 8
LISINOPRIL 155 127 12 5
LEVOTHYROXINE SODIUM 153 132 13 7
CLOPIDOGREL 152 126 14 28
OMEPRAZOLE 134 113 15 2
DIOVAN HCT 127 98 16 41
CLONIDINE HCL 125 76 17 32
ALLOPURINOL 119 95 18 31
METOPROLOL SUCCINATE 114 87 19 14
ATENOLOL 106 84 20 25
POTASSIUM CHLORIDE 104 92 21 9
NEXIUM 97 65 22 23
BENICAR HCT 94 81 23 180
JANUVIA 93 92 24 78
CILOSTAZOL 92 78 25 123
MELOXICAM 91 77 26 13
HYDROCODONE-ACETAMINOPHEN 89 53 S3 27 1
ISOSORBIDE MONONITRATE ER 85 78 28 54
ACETAMINOPHEN-CODEINE 81 62 S3 29 112
PRAVASTATIN SODIUM 79 65 30 11
GABAPENTIN 77 59 31 10
CRESTOR 71 40 32 29
PLAVIX 70 65 33 40
DONEPEZIL HCL 66 66 34 24
LIPITOR 64 48 35 94
GLIMEPIRIDE 63 62 36 30
CIPROFLOXACIN HCL 60 43 37 45
JANUMET 60 36 37 167
DEXILANT 56 36 39 155
TRAMADOL HCL 55 51 40 19
LOSARTAN POTASSIUM 54 53 41 34
RANITIDINE HCL 53 19 42 27
AZITHROMYCIN 53 35 42 39
CYCLOBENZAPRINE HCL 50 34 R 44 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.